Is arginine supplementation effective in preventing preeclampsia in pregnant women?

Objectives: The objective of this study was to review data from randomized controlled trials to assess whether or not the supplementation of L-Arginine (L-Arg) is effective in reducing the incidence of preeclampsia (PE) in pregnancies at risk of developing the disorder. Methods: We aimed to syste...

Full description

Bibliographic Details
Main Authors: Gabriel Citrangulo, Ana Luísa Scafura da Fonseca, Pedro Viana Diniz, João Pedro Torres Neiva Rodrigues, Denise Gasparetti Drumond
Format: Article
Language:Portuguese
Published: Universidade de São Paulo 2022-05-01
Series:Medicina
Subjects:
Online Access:https://www.revistas.usp.br/rmrp/article/view/184348
_version_ 1818541128738144256
author Gabriel Citrangulo
Ana Luísa Scafura da Fonseca
Pedro Viana Diniz
João Pedro Torres Neiva Rodrigues
Denise Gasparetti Drumond
author_facet Gabriel Citrangulo
Ana Luísa Scafura da Fonseca
Pedro Viana Diniz
João Pedro Torres Neiva Rodrigues
Denise Gasparetti Drumond
author_sort Gabriel Citrangulo
collection DOAJ
description Objectives: The objective of this study was to review data from randomized controlled trials to assess whether or not the supplementation of L-Arginine (L-Arg) is effective in reducing the incidence of preeclampsia (PE) in pregnancies at risk of developing the disorder. Methods: We aimed to systematic review randomized controlled trials, including those which compared L-Arg supplementation with placebo in pregnant women at high risk of PE development, analyzing PE incidence as the main outcome. Data were collected from MEDLINE/ Pubmed, EMBASE/ Elsevier, LILACS/ BVS and Cochrane.  Results: A total of 46 papers were identified in the primary search. After analysis of eligibility, inclusion and exclusion criteria, two articles (which respected in detail all the stages of evaluation) were included in the present review. A risk of bias assessment was performed. Data analysis revealed that the incidence of PE was significantly lower in both studies, and no major adverse effects were reported. The limitations of this study were the lack of standardization between the trials analyzed and the relative low number of studies included.  Conclusions: The supplementation with L-Arg appears to reduce the incidence of PE in pregnant women with high risk for its development.
first_indexed 2024-12-11T22:04:31Z
format Article
id doaj.art-32ef28db098e485294f9f333d0bfe626
institution Directory Open Access Journal
issn 0076-6046
2176-7262
language Portuguese
last_indexed 2024-12-11T22:04:31Z
publishDate 2022-05-01
publisher Universidade de São Paulo
record_format Article
series Medicina
spelling doaj.art-32ef28db098e485294f9f333d0bfe6262022-12-22T00:49:00ZporUniversidade de São PauloMedicina0076-60462176-72622022-05-01551Is arginine supplementation effective in preventing preeclampsia in pregnant women?Gabriel Citrangulo0Ana Luísa Scafura da Fonseca1Pedro Viana Diniz2João Pedro Torres Neiva Rodrigues3Denise Gasparetti Drumond4Universidade Federal de Juiz de ForaUniversidade Federal de Juiz de ForaUniversidade Federal de Juiz de ForaUniversidade Federal de Juiz de ForaUniversidade Federal de Juiz de Fora Objectives: The objective of this study was to review data from randomized controlled trials to assess whether or not the supplementation of L-Arginine (L-Arg) is effective in reducing the incidence of preeclampsia (PE) in pregnancies at risk of developing the disorder. Methods: We aimed to systematic review randomized controlled trials, including those which compared L-Arg supplementation with placebo in pregnant women at high risk of PE development, analyzing PE incidence as the main outcome. Data were collected from MEDLINE/ Pubmed, EMBASE/ Elsevier, LILACS/ BVS and Cochrane.  Results: A total of 46 papers were identified in the primary search. After analysis of eligibility, inclusion and exclusion criteria, two articles (which respected in detail all the stages of evaluation) were included in the present review. A risk of bias assessment was performed. Data analysis revealed that the incidence of PE was significantly lower in both studies, and no major adverse effects were reported. The limitations of this study were the lack of standardization between the trials analyzed and the relative low number of studies included.  Conclusions: The supplementation with L-Arg appears to reduce the incidence of PE in pregnant women with high risk for its development. https://www.revistas.usp.br/rmrp/article/view/184348PregnancyArgininePreeclampsiaSupplementationNitric oxide
spellingShingle Gabriel Citrangulo
Ana Luísa Scafura da Fonseca
Pedro Viana Diniz
João Pedro Torres Neiva Rodrigues
Denise Gasparetti Drumond
Is arginine supplementation effective in preventing preeclampsia in pregnant women?
Medicina
Pregnancy
Arginine
Preeclampsia
Supplementation
Nitric oxide
title Is arginine supplementation effective in preventing preeclampsia in pregnant women?
title_full Is arginine supplementation effective in preventing preeclampsia in pregnant women?
title_fullStr Is arginine supplementation effective in preventing preeclampsia in pregnant women?
title_full_unstemmed Is arginine supplementation effective in preventing preeclampsia in pregnant women?
title_short Is arginine supplementation effective in preventing preeclampsia in pregnant women?
title_sort is arginine supplementation effective in preventing preeclampsia in pregnant women
topic Pregnancy
Arginine
Preeclampsia
Supplementation
Nitric oxide
url https://www.revistas.usp.br/rmrp/article/view/184348
work_keys_str_mv AT gabrielcitrangulo isargininesupplementationeffectiveinpreventingpreeclampsiainpregnantwomen
AT analuisascafuradafonseca isargininesupplementationeffectiveinpreventingpreeclampsiainpregnantwomen
AT pedrovianadiniz isargininesupplementationeffectiveinpreventingpreeclampsiainpregnantwomen
AT joaopedrotorresneivarodrigues isargininesupplementationeffectiveinpreventingpreeclampsiainpregnantwomen
AT denisegasparettidrumond isargininesupplementationeffectiveinpreventingpreeclampsiainpregnantwomen